-
1
-
-
0033345349
-
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile
-
Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4006-4011
-
-
Diamanti-Kandarakis, E.1
Kouli, C.R.2
Bergiele, A.T.3
Filandra, F.A.4
Tsianateli, T.C.5
Spina, G.G.6
Zapanti, E.D.7
Bartzis, M.I.8
-
2
-
-
0034457559
-
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
-
Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF, A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 2434-2438
-
-
Asuncion, M.1
Calvo, R.M.2
San Millan, J.L.3
Sancho, J.4
Avila, S.5
Escobar-Morreale, H.F.6
-
3
-
-
0001217801
-
Diagnostic criteria for polycystic ovary syndrome: towards a rational approach
-
Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Boston: Blackwell
-
Zawadzki JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell 1992; 337-384.
-
(1992)
Polycystic ovary syndrome
, pp. 337-384
-
-
Zawadzki, J.K.1
Dunaif, A.2
-
4
-
-
0346725827
-
2004 Revised: Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
-
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised: Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2003; 81: 19-25.
-
(2003)
Fertil Steril
, vol.81
, pp. 19-25
-
-
-
5
-
-
15444366255
-
Polycystic ovary syndrome
-
Ehrmann DA: Polycystic ovary syndrome. N Engl J Med 2005; 352: 223-236.
-
(2005)
N Engl J Med
, vol.352
, pp. 223-236
-
-
Ehrmann, D.A.1
-
6
-
-
0023189131
-
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia
-
Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A: Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65: 499-4507.
-
(1987)
J Clin Endocrinol Metab
, vol.65
, pp. 499-4507
-
-
Dunaif, A.1
Graf, M.2
Mandeli, J.3
Laumas, V.4
Dobrjansky, A.5
-
7
-
-
0027301374
-
The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries
-
Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S: The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-355.
-
(1993)
Clin Endocrinol
, vol.39
, pp. 351-355
-
-
Robinson, S.1
Kiddy, D.2
Gelding, S.V.3
Willis, D.4
Niththyananthan, R.5
Bush, A.6
Johnston, D.G.7
Franks, S.8
-
8
-
-
33646417382
-
Genetic and environmental origins of obesity relevant to reproduction
-
Franks S: Genetic and environmental origins of obesity relevant to reproduction. Reprod Biomed Online 2006; 12: 526-531.
-
(2006)
Reprod Biomed Online
, vol.12
, pp. 526-531
-
-
Franks, S.1
-
9
-
-
0024437305
-
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
-
Dunai fA, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38:1165-1174.
-
(1989)
Diabetes
, vol.38
, pp. 1165-1174
-
-
Dunaif, A.1
Segal, K.R.2
Futterweit, W.3
Dobrjansky, A.4
-
10
-
-
79953799341
-
Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-A meta-analysis of randomized trails
-
Johnson N: Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-A meta-analysis of randomized trails. Aust N Z J Obstet Gynaecol 2011; 51: 125-129.
-
(2011)
Aust N Z J Obstet Gynaecol
, vol.51
, pp. 125-129
-
-
Johnson, N.1
-
11
-
-
33750201631
-
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
-
Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS: A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006; 12: 673-683.
-
(2006)
Hum Reprod Update
, vol.12
, pp. 673-683
-
-
Boomsma, C.M.1
Eijkemans, M.J.2
Hughes, E.G.3
Visser, G.H.4
Fauser, B.C.5
Macklon, N.S.6
-
12
-
-
84886396618
-
Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review
-
Lautatzis ME, Goulis DG, Vrontakis M: Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism 2013; 62:1522-1534.
-
(2013)
Metabolism
, vol.62
, pp. 1522-1534
-
-
Lautatzis, M.E.1
Goulis, D.G.2
Vrontakis, M.3
-
13
-
-
33748099537
-
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis
-
Gilbert C, Valois M, Koren G: Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86: 658-663.
-
(2006)
Fertil Steril
, vol.86
, pp. 658-663
-
-
Gilbert, C.1
Valois, M.2
Koren, G.3
-
14
-
-
68049122102
-
PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
-
Moher D, Liberati A, TetzlaffJ, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
-
(2009)
PLoS Med
, vol.6
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
17
-
-
0028659004
-
Operating characteristics of a rank correlation test for publication bias
-
Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
-
(1994)
Biometrics
, vol.50
, pp. 1088-1101
-
-
Begg, C.B.1
Mazumdar, M.2
-
18
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey, S.G.2
Schneider, M.3
Minder, C.4
-
19
-
-
40549132473
-
Estimation of fail-Safe number in meta-analysis
-
Mai JZ, Li H, Fang JQ, Liu XQ, Rao XX: Estimation of fail-Safe number in meta-analysis. The Journal of Evidence-Based medicine 2006; 6: 297-300, 303.
-
(2006)
The Journal of Evidence-Based medicine
, vol.6
-
-
Mai, J.Z.1
Li, H.2
Fang, J.Q.3
Liu, X.Q.4
Rao, X.X.5
-
21
-
-
78650059171
-
Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study
-
Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogøy K, Kleggetveit O, Hjelle S, von Brandis P, Eikeland T, Flo K, Berg KF, Bunford G, Lund A, Bjerke C, Almås I, Berg AH, Danielson A, Lahmami G, Carlsen SM: Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010; 95: E448-E455.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. E448-E455
-
-
Vanky, E.1
Stridsklev, S.2
Heimstad, R.3
Romundstad, P.4
Skogøy, K.5
Kleggetveit, O.6
Hjelle, S.7
von Brandis, P.8
Eikeland, T.9
Flo, K.10
Berg, K.F.11
Bunford, G.12
Lund, A.13
Bjerke, C.14
Almås, I.15
Berg, A.H.16
Danielson, A.17
Lahmami, G.18
Carlsen, S.M.19
-
22
-
-
63149092470
-
Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome
-
Begum MR, Khanam NN, Quadir E, Ferdous J, Begum MS, Khan F, Begum A: Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2009; 35: 282-286.
-
(2009)
J Obstet Gynaecol Res
, vol.35
, pp. 282-286
-
-
Begum, M.R.1
Khanam, N.N.2
Quadir, E.3
Ferdous, J.4
Begum, M.S.5
Khan, F.6
Begum, A.7
-
23
-
-
4344651482
-
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study
-
Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM: Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19: 1734-1740.
-
(2004)
Hum Reprod
, vol.19
, pp. 1734-1740
-
-
Vanky, E.1
Salvesen, K.A.2
Heimstad, R.3
Fougner, K.J.4
Romundstad, P.5
Carlsen, S.M.6
-
24
-
-
80053902515
-
Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome?. Prospective cohort study
-
Khattab S, Mohsen IA, Aboul Foutouh I, Ashmawi HS, Mohsen MN, van Wely M, van der Veen F, Youssef MA: Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 2011; 27: 789-793.
-
(2011)
Gynecol Endocrinol
, vol.27
, pp. 789-793
-
-
Khattab, S.1
Mohsen, I.A.2
Aboul Foutouh, I.3
Ashmawi, H.S.4
Mohsen, M.N.5
van Wely, M.6
van der Veen, F.7
Youssef, M.A.8
-
25
-
-
80053282262
-
The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome
-
Hameed A, Shreif H, Mowafy H: The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome. Middle East Fertility Society Journal 2011; 16: 204-208.
-
(2011)
Middle East Fertility Society Journal
, vol.16
, pp. 204-208
-
-
Hameed, A.1
Shreif, H.2
Mowafy, H.3
-
26
-
-
52049089236
-
Does continuous use of metformin throughout pregnancy improves pregnancy outcomes in women with polycystic ovarian syndrome?
-
Nawaz FH, Khalid R, Naru T, Rizvi J: Does continuous use of metformin throughout pregnancy improves pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 2008; 34: 832-837.
-
(2008)
J Obstet Gynaecol Res
, vol.34
, pp. 832-837
-
-
Nawaz, F.H.1
Khalid, R.2
Naru, T.3
Rizvi, J.4
-
27
-
-
72149097638
-
Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome
-
Nawaz FH, Rizvi J: Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 2010; 69: 184-189.
-
(2010)
Gynecol Obstet Invest
, vol.69
, pp. 184-189
-
-
Nawaz, F.H.1
Rizvi, J.2
-
28
-
-
33845607644
-
Metformin reduces abortion in pregnant women with polycystic ovary syndrome
-
Kh Khattab S, Mohsen IA, Foutouh IA, Ramadan A, Moaz M, Al-Inany H: Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol 2006; 22: 680-684.
-
(2006)
Gynecol Endocrinol
, vol.22
, pp. 680-684
-
-
Kh Khattab, S.1
Mohsen, I.A.2
Foutouh, I.A.3
Ramadan, A.4
Moaz, M.5
Al-Inany, H.6
-
29
-
-
0036171653
-
Effects of metformin on early pregnancy loss in the polycystic ovary syndrome
-
Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE: Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 524-529.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 524-529
-
-
Jakubowicz, D.J.1
Iuorno, M.J.2
Jakubowicz, S.3
Roberts, K.A.4
Nestler, J.E.5
-
30
-
-
0036181614
-
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome
-
Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L: Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520-525.
-
(2002)
Fertil Steril
, vol.77
, pp. 520-525
-
-
Glueck, C.J.1
Wang, P.2
Kobayashi, S.3
Phillips, H.4
Sieve-Smith, L.5
-
31
-
-
0035168622
-
Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study
-
Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P: Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001; 75: 46-52.
-
(2001)
Fertil Steril
, vol.75
, pp. 46-52
-
-
Glueck, C.J.1
Phillips, H.2
Cameron, D.3
Sieve-Smith, L.4
Wang, P.5
-
32
-
-
0029796476
-
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
-
Nestler JE, Jakubowicz DJ: Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335: 617-623.
-
(1996)
N Engl J Med
, vol.335
, pp. 617-623
-
-
Nestler, J.E.1
Jakubowicz, D.J.2
-
33
-
-
33746220070
-
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
-
Diamanti-Kandarakis E, Papavasiliou A: Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006; 12: 324-332.
-
(2006)
Trends Mol Med
, vol.12
, pp. 324-332
-
-
Diamanti-Kandarakis, E.1
Papavasiliou, A.2
-
34
-
-
0034892698
-
Metformin directly inhibits androgen production in human thecal cells
-
Attia GR, Rainey WE, Carr BR: Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 2001; 76: 517-524.
-
(2001)
Fertil Steril
, vol.76
, pp. 517-524
-
-
Attia, G.R.1
Rainey, W.E.2
Carr, B.R.3
-
35
-
-
33747624148
-
Metformin induced stimulation of adenosine 50 monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells
-
Tosca L, Solnais P, Ferre P, Foufelle F, Dupont J: Metformin induced stimulation of adenosine 50 monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol Reprod 2006; 75: 342-351.
-
(2006)
Biol Reprod
, vol.75
, pp. 342-351
-
-
Tosca, L.1
Solnais, P.2
Ferre, P.3
Foufelle, F.4
Dupont, J.5
-
36
-
-
33747893345
-
The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice
-
Elia E, Sander V, Luchetti CG, Solano ME, Di Girolamo G, Gonzalez C, Motta AB: The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Mol Hum Reprod 2006; 12: 475-481.
-
(2006)
Mol Hum Reprod
, vol.12
, pp. 475-481
-
-
Elia, E.1
Sander, V.2
Luchetti, C.G.3
Solano, M.E.4
Di Girolamo, G.5
Gonzalez, C.6
Motta, A.B.7
-
37
-
-
24944486315
-
Adenosine 50-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells
-
Tosca L, Froment P, Solnais P, Ferré P, Foufelle F, Dupont J: Adenosine 50-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 2005; 146: 4500-4513.
-
(2005)
Endocrinology
, vol.146
, pp. 4500-4513
-
-
Tosca, L.1
Froment, P.2
Solnais, P.3
Ferré, P.4
Foufelle, F.5
Dupont, J.6
-
38
-
-
4444321538
-
Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome
-
Practice Committee of the American Society for Reproductive Medicine: Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome. Fertil Steril 2004; 82: S181-S183.
-
(2004)
Fertil Steril
, vol.82
, pp. S181-S183
-
-
-
39
-
-
0142247208
-
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
-
Lord JM, Flight IH, Norman RJ: Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951-953.
-
(2003)
BMJ
, vol.327
, pp. 951-953
-
-
Lord, J.M.1
Flight, I.H.2
Norman, R.J.3
-
40
-
-
0037229222
-
A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome
-
Costello MF, Eden JA: A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003; 79: 1-13.
-
(2003)
Fertil Steril
, vol.79
, pp. 1-13
-
-
Costello, M.F.1
Eden, J.A.2
-
41
-
-
1842678279
-
Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
-
Cheang KI, Nestler JE: Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reprod Biomed Online 2004; 8: 440-447.
-
(2004)
Reprod Biomed Online
, vol.8
, pp. 440-447
-
-
Cheang, K.I.1
Nestler, J.E.2
-
42
-
-
0142185995
-
Insulin-lowering agents in the management of polycystic ovary syndrome
-
De Leo V, La Marca A, Petraglia F: Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003; 24: 633-667.
-
(2003)
Endocr Rev
, vol.24
, pp. 633-667
-
-
De Leo, V.1
La Marca, A.2
Petraglia, F.3
-
43
-
-
34548784576
-
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome
-
Palomba S, Orio F Jr, Falbo A, Russo T, Tolino A, Zullo F: Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 3579-3584.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 3579-3584
-
-
Palomba, S.1
Orio, F.2
Falbo, A.3
Russo, T.4
Tolino, A.5
Zullo, F.6
-
44
-
-
23044513823
-
Prospective parallel randomized, doubleblind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome
-
Palomba S, Orio F Jr, Falbo A: Prospective parallel randomized, doubleblind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 4068-4074.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 4068-4074
-
-
Palomba, S.1
Orio, F.2
Falbo, A.3
-
45
-
-
33845747700
-
Comparison of clomiphene citrate, metformin or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome
-
Neveu N, Granger L, St-Michel P, Lavoie HB: Comparison of clomiphene citrate, metformin or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome. Fertil Steril 2007; 87: 113-120.
-
(2007)
Fertil Steril
, vol.87
, pp. 113-120
-
-
Neveu, N.1
Granger, L.2
St-Michel, P.3
Lavoie, H.B.4
-
46
-
-
0142247208
-
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
-
Lord JM, Flight IH, Norman RJ: Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951-953.
-
(2003)
BMJ
, vol.327
, pp. 951-953
-
-
Lord, J.M.1
Flight, I.H.2
Norman, R.J.3
-
47
-
-
33846875851
-
Cooperative Multicenter Reproductive Medicine Network: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
-
Legro RS, Barnhart HX, SchlaffWD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER; Cooperative Multicenter Reproductive Medicine Network: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356: 551-566.
-
(2007)
N Engl J Med
, vol.356
, pp. 551-566
-
-
Legro, R.S.1
Barnhart, H.X.2
Schlaff, W.D.3
Carr, B.R.4
Diamond, M.P.5
Carson, S.A.6
Steinkampf, M.P.7
Coutifaris, C.8
McGovern, P.G.9
Cataldo, N.A.10
Gosman, G.G.11
Nestler, J.E.12
Giudice, L.C.13
Leppert, P.C.14
Myers, E.R.15
-
48
-
-
33749021080
-
A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome
-
Costello MF, Chapman M, Conway U: A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 2006; 21: 1387-1399.
-
(2006)
Hum Reprod
, vol.21
, pp. 1387-1399
-
-
Costello, M.F.1
Chapman, M.2
Conway, U.3
-
49
-
-
33745670469
-
The use of metformin for women with PCOS undergoing IVF treatment
-
Tang T, Glanville J, Orsi N, Barth JH, Balen AH: The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006; 21: 1416-1425.
-
(2006)
Hum Reprod
, vol.21
, pp. 1416-1425
-
-
Tang, T.1
Glanville, J.2
Orsi, N.3
Barth, J.H.4
Balen, A.H.5
-
50
-
-
0035044332
-
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome
-
Jakubowicz DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R, Nestler JE: Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 1126-1133.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1126-1133
-
-
Jakubowicz, D.J.1
Seppälä, M.2
Jakubowicz, S.3
Rodriguez-Armas, O.4
Rivas-Santiago, A.5
Koistinen, H.6
Koistinen, R.7
Nestler, J.E.8
-
51
-
-
24944444302
-
Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome
-
Palomba S, Orio F Jr, Falbo A, Russo T, Tolino A, Zullo F: Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome. Fertil Steril 2005; 84: 761-765.
-
(2005)
Fertil Steril
, vol.84
, pp. 761-765
-
-
Palomba, S.1
Orio, F.2
Falbo, A.3
Russo, T.4
Tolino, A.5
Zullo, F.6
-
52
-
-
34548432258
-
AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations
-
Eng GS, Sheridan RA, Wyman A, Chi MM-Y, Bibee KP, Jungheim ES, Moley KH: AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations. Diabetes 2007; 56: 2228-2234.
-
(2007)
Diabetes
, vol.56
, pp. 2228-2234
-
-
Eng, G.S.1
Sheridan, R.A.2
Wyman, A.3
Chi, M.M.-Y.4
Bibee, K.P.5
Jungheim, E.S.6
Moley, K.H.7
-
53
-
-
84887111250
-
The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials
-
Zheng J, Shan PF, Gu W: The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials. J Endocrinol Invest 2013; 36: 797-802.
-
(2013)
J Endocrinol Invest
, vol.36
, pp. 797-802
-
-
Zheng, J.1
Shan, P.F.2
Gu, W.3
-
54
-
-
84902181405
-
Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis
-
Zhuo Z, Wang A, Yu H: Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Diabetes Res 2014; 2014: 1-13.
-
(2014)
J Diabetes Res
, vol.2014
, pp. 1-13
-
-
Zhuo, Z.1
Wang, A.2
Yu, H.3
|